Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Antihypertensive combination cleared for marketing in the U.S.

Oct. 18, 1996

PRAISE trial demonstrates safety of calcium channel blocker in severe heart failure

Oct. 18, 1996

Significant progress in cardiovascular R&D at Yamanouchi

Oct. 11, 1996

BTG licenses drug for cardiac arrest

Oct. 11, 1996

New approval for carvedilol in congestive heart failure

Oct. 11, 1996

Clinical results with adenosine agonist

Oct. 11, 1996

Lynx licenses antisense compound for restenosis to Schwarz

Oct. 11, 1996

New antioxidant for atherosclerosis

Oct. 11, 1996

MTP inhibitors from Bristol-Myers Squibb

Oct. 11, 1996

Neurex and Beaufour Ipsen reach licensing agreement for Corlopam

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...